Advances in oral controlled release drug delivery systems
Department of Pharmaceutics, Shri Swami Samarth Institute of Pharmacy, At Parsodi, Dhamangaon Rly, Dist -Amravati (444709) Maharashtra, India.
Review Article
GSC Biological and Pharmaceutical Sciences, 2024, 29(03), 286-297.
Article DOI: 10.30574/gscbps.2024.29.3.0475
Publication history:
Received on 10 November 2024; revised on 18 December 2024; accepted on 21 December 2024
Abstract:
Controlled Drug Delivery Systems (CDDS) represent a significant advancement in pharmaceutical technology, designed to deliver therapeutic agents in a controlled and sustained manner over an extended period. These systems aim to optimize the drug's efficacy by maintaining therapeutic drug levels in the body, reducing side effects, and enhancing patient compliance. CDDS can be classified into various categories, including polymeric, liposomal, and nanoparticle-based systems, each offering unique benefits. Polymeric systems, for example, allow for the precise release of drugs through diffusion, degradation, or swelling mechanisms. Drugs can be targeted to certain tissues with the use of liposomes and nanoparticles, increasing the therapeutic index while lowering systemic exposure. To further improve the accuracy of drug administration, CDDS can also be made to react to environmental stimuli like pH, temperature, or electromagnetic fields. The creation of CDDS has been the subject of extensive research in recent decades in order to solve issues such patient adherence, drug stability, and bioavailability. With the development of new materials and technology, CDDS remains a promising treatment option for cancer, chronic diseases, and other complex medical problems, offering more individualized and efficient therapeutic alternatives.
Keywords:
Controlled Release Drug Delivery Systems; Prolonged; Bioavailability; Compliance; Medicine
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
